Christopher Roberts

Title: Christopher Roberts: Innovator in Molecular Diagnostics

Introduction

Christopher Roberts is an accomplished inventor based in Tucson, AZ. He has made significant contributions to the field of molecular diagnostics, particularly in the study of melanocytic lesions. His innovative work has the potential to improve the accuracy of melanoma diagnoses.

Latest Patents

Roberts holds a patent for "Molecular malignancy in melanocytic lesions." This patent discloses methods for determining whether a melanocyte-containing sample, such as a nevus or other pigmented lesion, is benign or a primary melanoma. The methods include detecting the expression of at least two disclosed genes at the molecular level, such as mRNA, miRNA, or protein, in a biological sample obtained from a subject. Additionally, the patent provides arrays and kits that can be utilized with these methods.

Career Highlights

Throughout his career, Christopher Roberts has worked with notable organizations, including Htg Molecular Diagnostics, Inc. and the John Wayne Cancer Institute. His experience in these institutions has allowed him to develop and refine his expertise in molecular diagnostics.

Collaborations

Roberts has collaborated with esteemed colleagues, including Hui Wang and Krishna Maddula. These partnerships have contributed to the advancement of research in the field of melanoma and molecular diagnostics.

Conclusion

Christopher Roberts is a pioneering inventor whose work in molecular diagnostics has the potential to transform the way melanocytic lesions are evaluated. His contributions to the field are invaluable and continue to influence future research and clinical practices.